Since Casp6 has many neuronal protein substrates, it is reasonable to conclude that Casp6-mediated damage occurs in many pathways that contribute to neurodegeneration and it may be more important to target Casp6 rather than its substrates in AD. This evidence concerns the gene CASP6 and Alzheimer disease.